Effect of Patoladi kwatha and Khadir kwatha in management of Ekakushtha(Plaque psoriasis)

Comparative clinical study to evaluate the efficacy of Patoladi kwatha and Khadir kwatha in improving PASI score in Ekakushtha(Plaque psoriasis) - Nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100847

Enrollment

Registered

2026-01-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient showing sign and symptoms of Ekakushtha (as per Acharya Charak- Matsyashakalopamam, Mahavastu, Aswedanam) 2) PASI score required for study within the range of more than or equal to 1 and less than or equal to 11. 3) Patient within the age group of 21-60 years. 4) Patients who are ready to give consent.

Exclusion criteria

Exclusion criteria: 1) Seriously ill patients. 2) Incompatibility with drugs chosen for the study. 3) Abnormal renal or hepatic functions. 4) Patients planning to conceive in near future (during course of trial) 5) Pregnant & lactating mother. 6) Any major psychiatric illness 7) Any other pre-existing illness that will require surgery during course of trial 8) Subjects who are not willing for trial. 9) Patients PASI score more than 11.

Design outcomes

Primary

Measure	Time frame
Improvement in Psoriasis Area and Severity Index (PASI) Score.Timepoint: Day0 and Day 45	—

Secondary

Measure	Time frame
Improvement in symptom severity of Ekakushtha (Plaque Psoriasis).Timepoint: 45days	—

Countries

India

Contacts

Public ContactProf Dr Atal Bihari Trivedi

Ch Brahm Prakash Ayurved Charak Sansthan

abdratal8@gmail.com9958046550

Outcome results